ProCE Banner Activity

Driving Improved Outcomes in Resectable Melanoma: Pathways for Optimized Adjuvant Immunotherapy Strategies

Slideset

Expert faculty–curated slideset on strategies to improve outcomes in resectable melanoma by optimizing pathways in using adjuvant immunotherapy to treat this disease.

Released: October 14, 2024

Expiration: October 13, 2025

Share

Faculty

Jason Luke

Jason Luke, MD, FACP

Associate Director for Clinical Research
Director, Immunotherapy and Drug Development Center
Associate Professor of Medicine
UPMC Hillman Cancer Center 
University of Pittsburgh
Pittsburgh, Pennsylvania

Govind Warrier

Govind Warrier, MD, MPH

Assistant Professor, Medical Oncology
Melanoma/Skin Cancer and Cancer Immunology Programs
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC, in partnership with AIM at Melanoma Foundation.

ProCE Banner

Supporters

Supported by an educational grant from Bristol-Myers Squibb.

Bristol Myers Squibb

Partners

AIM at Melanoma Foundation

ProCE Banner